HealthNet - All plan years
Mirvaso (brimonidine)
Drugs for the Skin : Drugs for the Skin
  • Acromegaly:
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Reauthorization Required: No
    Duration of Reauthorization: N/A

    Neuroendocrine Tumor (NET):
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: No
    Duration of Reauthorization: N/A

    Oncology: Carcinoid Syndrome:
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: No
    Duration of Reauthorization: N/A
    Requires diagnosis of Carcinoid syndrome with diarrhea: No
    Concomitant Therapy Required with Somatostatin Analog Therapy: No
    Patient Required to Try Increased Dosage of Sandostatin: No

  • ST_APPLIES
  • Pemphigus Vulgaris:
    Duration: 1 year(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: No
    Duration of Reauthorization: N/A

    PID: Immune Globulin:
    Duration: 1 year(s)
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Reauthorization Required: No
    Duration of Reauthorization: N/A
    Documented inability to mount an immune response: Yes
    Documentation of severe infection despite prophylactic ABX treatment: Yes
    Documented Serum IgG Level: Unspecified
    IgG Subclass Level Referencing Standard Deviation Below Age Adjusted Mean: > 2
    Supporting Documentation Requirements: Medical Tests